API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
Canada
0
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.biopharmadive.com/news/axsome-narcolepsy-drug-clinical-trial-results/711249/
https://www.globenewswire.com/news-release/2020/01/13/1969353/0/en/Axsome-Therapeutics-Enters-into-Exclusive-License-Agreement-with-Pfizer-Inc-for-Pfizer-s-Reboxetine-Clinical-and-Nonclinical-Data-and-for-New-Phase-3-Esreboxetine-Product-Candidate.html
https://www.biospace.com/article/releases/axsome-therapeutics-completes-patient-enrollment-in-the-concert-phase-2-trial-of-axs-12-in-narcolepsy/?s=95